Figure 4. Risk of Melanoma and Keratinocyte Carcinoma After Topical Calcineurin Inhibitor (TCI) Treatment.
Relative risks (RRs) were calculated using random-effects inverse variance method. Marker size indicates weight; diamond size indicates heterogeneity. PIM indicates pimecrolimus; TAC, tacrolimus; TCS, topical corticosteroid.
aIndicates melanoma.
bIndicates keratinocyte carcinoma.